Atlas Trials

Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors

Clinical trial NCT01095302 · COMPLETED

Trial details

NCT number
NCT01095302
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms, Malignant
Start date
2010-05-01
Primary completion
2011-12-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.